Selection of cord blood unit(s) for transplantation.

Selection of cord blood (CB) units for transplantation involves combining both cell dose and HLA matching as independent yet overlapping variables. Cell dose and cell yield at the time of transplant are critical given that the transplants are being performed with minimal cells for reliable engraftment. In transplants for malignant disorders, the greater allogenicity and lower relapse rate associated with the less well-matched units balance any benefit of better HLA matching on TRM. The only factor that has repeatedly been associated with improved outcome post CB transplant is cell dose. The CB inventories are rapidly increasing in size and the quality of CB units being banked (larger, better characterized) is improving. With this, some of our current limitations in CB availability will soon become moot. Explorations into CB expansion and multiple CB unit transplants are addressing the limited cell doses attainable with a single CB collection.1, 2, 3, 4 At this point, one must conclude that bigger is better when selecting CB units for transplantation.Bone Marrow Transplantation (2008) 42, 1–7; doi:10.1038/bmt.2008.100; published online 12 May 2008 [ABSTRACT FROM AUTHOR]